Propylthiouracil

DRUG4 trials

Sponsors

Ankara University, Newcastle-upon-Tyne Hospitals NHS Trust, Indonesia University, Maastricht University

Conditions

Atherosclerosis of ArteryGraves DiseaseGraves' OphthalmopathyHyperthyroidismIschemic Stroke, AcutePaediatric ThyrotoxicosisPathophysiology

Phase 2

Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE

Maastricht UniversityIschemic Stroke, Acute

Start: 2022-09-05End: 2024-04-30Target: 28Updated: 2023-10-19

Phase 3

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

CompletedNCT01436994

Newcastle-upon-Tyne Hospitals NHS TrustPaediatric Thyrotoxicosis

Start: 2004-07-31End: 2015-11-30Updated: 2016-09-21

Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis

CompletedNCT05118542

Indonesia UniversityAtherosclerosis of Artery, Graves Disease, Hyperthyroidism +1

Start: 2019-01-01End: 2020-08-01Updated: 2021-11-12

Phase 4

The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy

Ankara UniversityGraves' Ophthalmopathy

Start: 2009-01-31End: 2010-08-31Target: 40Updated: 2010-01-26

Related Papers

Synergistic Network Pharmacology: Preclinical Validation and Clinical Safety in Acute Ischemic Stroke

Journal of the American Heart Association2025-05-152 citations

The Effects of Anti-thyroid Drugs on Lipoproteins and Insulin Resistance in Graves’ Disease: A Randomized Clinical Trial

Journal of Lipid and Atherosclerosis2024-01-012 citations